Lots More Information

Resources

• www.niaid.nih.gov -- National Institute of Allergy and Infectious Disease
• www.cdc.gov/ncidod/dvbid/lyme -- Centers for Disease Control
• www.lyme.org -- Lyme Disease Foundation
• www.aldf.com -- American Lyme Disease Foundation
• www.lymenet.org -- Lyme Disease Network
• www.idsociety.org -- Infectious Diseases Society of America
• www.rheumatology.org -- American College of Rheumatology
• www.arthritis.org -- The Arthritis Foundation

References

U.S. Centers for Disease Control and Prevention. Caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep. 2005;54(5):125.

Coulter P, Lema C, Flayhart D, Linhardt AS, Aucott JN, Auwaerter PG, et al. Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J Clin Microbiol. 2005;43(10):5080-5084.

Demma LJ, Traeger MS, Nicholson WL, Paddock CD, Blau DM, Eremeeva ME, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med. 2005;353(6):587-594.

Dumler JS, Walker DH. Rocky Mountain spotted fever--changing ecology and persisting virulence. N Engl J Med. 2005;353(6):551-553.

Gomes-Solecki MJ, Brisson DR, Dattwyler RJ. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine. 2005 Sep 27; [Epub ahead of print].

Rauter C, Mueller M, Diterich I, Zeller S, Hassler D, Meergans T, et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol. 2005;12(8):910-917.

Scheckelhoff MR, Telford SR, Hu LT. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine. 2005 Nov 4; [Epub ahead of print].